Mark S. Wuttke, Ph.D.
Before Asten’s formation in 2007, Dr. Wuttke was with the U.S. Major Pharmaceuticals group in the Equity Research Department of Credit Suisse where he evaluated marketed and investigational pharmaceutical products and modeled therapeutic areas. Prior to joining Credit Suisse, Dr. Wuttke consulted to the healthcare industry with Booz Allen Hamilton, where his clients included global pharmaceutical companies, biotechnology companies and the U.S. Food and Drug Administration. His projects included an analysis of R&D productivity and pipeline success within the pharmaceutical and biotechnology industries, strategy development to balance multi-national clinical manufacturing operations for a top-10 pharmaceutical company and review of the FDA's regulatory approval process. Prior to joining Booz Allen, Dr. Wuttke managed the sales and marketing team at Cognia Corporation, a life-science information management company based in New York City. At Cognia, Dr. Wuttke directed a team of 5 sales representatives to generate a sales pipeline of over 200 pharmaceutical, biotech and academic customers resulting in $2.7MM in sales. Dr. Wuttke was a Post-Doctoral Fellow at Cornell University's Weill Medical College where he published his results in leading peer-reviewed journals. Dr. Wuttke holds a Ph.D. in Biology (Genetics) from Temple University and a B.S. in Biology from St. Joseph's University.